STOCK TITAN

Retrieve Medical Holdings Inc Financials

rmhi
Source SEC Filings (10-K/10-Q) Updated Dec 31, 2022 Currency USD FYE September

This page shows Retrieve Medical Holdings Inc (rmhi) financial statements, including the income statement, balance sheet, cash flow statement, and key financial ratios. View 14 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Financial Health Signals

Piotroski F-Score Weak
2/9

Retrieve Medical Holdings Inc passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass.

Earnings Quality Low Quality
0.42x

For every $1 of reported earnings, Retrieve Medical Holdings Inc generates $0.42 in operating cash flow (-$69K OCF vs -$165K net income). This low ratio suggests earnings are primarily driven by accounting accruals rather than cash generation, which may not be sustainable.

Interest Coverage At Risk
-5.1x

Retrieve Medical Holdings Inc earns $-5.1 in operating income for every $1 of interest expense (-$163K vs $32K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV
Revenue
N/A
EBITDA
N/A
Free Cash Flow
N/A
Net Income
-$165K
YoY-116.8%

Retrieve Medical Holdings Inc reported -$165K in net income in fiscal year 2022. This represents a decrease of 116.8% from the prior year.

EPS (Diluted)
N/A
Cash & Debt
$128K
YoY-51.1%
10Y CAGR+38.4%

Retrieve Medical Holdings Inc held $128K in cash against $0 in long-term debt as of fiscal year 2022.

Dividends Per Share
N/A
Shares Outstanding
78M
YoY+0.0%
5Y CAGR+0.0%

Retrieve Medical Holdings Inc had 78M shares outstanding in fiscal year 2022. This represents an increase of 0.0% from the prior year.

Gross Margin
N/A
Operating Margin
N/A
Net Margin
N/A
Return on Equity
N/A
R&D Spending
N/A
Share Buybacks
N/A
Capital Expenditures
N/A

rmhi Income Statement

Metric Q1'23 Q1'22 Q3'22 Q3'22 Q1'22 Q3'21 Q3'21 Q3'21
Revenue $0 N/A $0 $0 N/A N/A $0 N/A
Cost of Revenue $0 N/A $0 $0 N/A N/A N/A N/A
Gross Profit $0 N/A $0 $0 N/A N/A N/A N/A
R&D Expenses N/A N/A N/A N/A N/A N/A N/A N/A
SG&A Expenses $110K N/A $12K-74.0% $47K-10.6% $52K N/A $17K-61.0% $43K
Operating Income -$110K N/A -$12K+74.0% -$47K+10.6% -$52K N/A -$17K+61.0% -$43K
Interest Expense $2K N/A $8K-0.6% $8K-9.4% $9K N/A $2K-5.5% $2K
Income Tax N/A N/A $0 N/A N/A N/A $0 N/A
Net Income -$112K N/A $9K+116.2% -$55K+8.1% -$59K N/A -$19K+55.0% -$43K
EPS (Diluted) N/A N/A $0.00 N/A N/A N/A N/A N/A

rmhi Balance Sheet

Metric Q1'23 Q1'22 Q3'22 Q3'22 Q1'22 Q3'21 Q3'21 Q3'21
Total Assets $102K-21.4% $130K-2.8% $134K-25.6% $180K-6.7% $193K-26.1% $261K+510.3% $43K+12195.4% $348
Current Assets $1K-9.6% $1K-17.2% $2K-16.5% $2K N/A N/A N/A $348
Cash & Equivalents $97K-24.2% $128K-2.8% $131K-25.4% $176K-6.1% $188K-28.2% $261K+510.3% $43K+12195.4% $348
Inventory N/A N/A N/A N/A N/A N/A N/A N/A
Accounts Receivable N/A N/A N/A N/A N/A N/A N/A N/A
Goodwill N/A N/A N/A N/A N/A N/A N/A N/A
Total Liabilities $706K+13.6% $622K+9.9% $565K-8.9% $620K+7.2% $579K-1.5% $587K+62.2% $362K-93.0% $5.2M
Current Liabilities $145K+1.2% $143K+2.8% $139K+7.4% $129K N/A N/A N/A $301K
Long-Term Debt N/A N/A N/A N/A N/A N/A N/A N/A
Total Equity -$603K-22.9% -$491K-13.9% -$431K+2.0% -$440K-14.2% -$386K-18.2% -$326K-2.1% -$319K+93.8% -$5.2M
Retained Earnings -$5.5M-2.1% -$5.4M-1.1% -$5.3M+0.2% -$5.3M-1.0% -$5.2M-1.1% -$5.2M-0.1% -$5.2M-0.4% -$5.2M

rmhi Cash Flow Statement

Metric Q1'23 Q1'22 Q3'22 Q3'22 Q1'22 Q3'21 Q3'21 Q3'21
Operating Cash Flow -$31K-725.4% -$4K+61.6% -$10K+15.1% -$11K+73.7% -$44K-208.4% -$14K-23460.0% -$60-100.0% -$30
Capital Expenditures N/A $0 $0 N/A N/A N/A N/A N/A
Free Cash Flow N/A -$271+99.9% -$400K N/A N/A N/A N/A N/A
Investing Cash Flow $0 $0 $0 $0 N/A N/A N/A N/A
Financing Cash Flow -$126 $0+100.0% -$35K $0+100.0% -$30K-112.9% $233K N/A N/A
Dividends Paid N/A N/A N/A N/A N/A N/A N/A N/A
Share Buybacks N/A N/A N/A N/A N/A N/A N/A N/A

rmhi Financial Ratios

Metric Q1'23 Q1'22 Q3'22 Q3'22 Q1'22 Q3'21 Q3'21 Q3'21
Gross Margin N/A N/A N/A N/A N/A N/A N/A N/A
Operating Margin N/A N/A N/A N/A N/A N/A N/A N/A
Net Margin N/A N/A N/A N/A N/A N/A N/A N/A
Return on Equity N/A N/A N/A N/A N/A N/A N/A N/A
Return on Assets -109.5% N/A 6.6%+36.9pp -30.3%+0.5pp -30.8% N/A -44.9%+12228.7pp -12273.6%
Current Ratio 0.010.0 0.010.0 0.010.0 0.01 N/A N/A N/A 0.00
Debt-to-Equity -1.17+0.1 -1.27+0.0 -1.31+0.1 -1.41+0.1 -1.50+0.3 -1.80-0.7 -1.13-0.1 -1.00
FCF Margin N/A N/A N/A N/A N/A N/A N/A N/A

Note: Shareholder equity is negative (-$491K), which causes debt-to-equity and return on equity ratios to appear negative or not meaningful. This can occur from accumulated losses or large share buyback programs.

Similar Companies

Frequently Asked Questions

Is Retrieve Medical Holdings Inc profitable?

No, Retrieve Medical Holdings Inc (rmhi) reported a net income of -$165K in fiscal year 2022.

What is Retrieve Medical Holdings Inc's operating cash flow?

Retrieve Medical Holdings Inc (rmhi) generated -$69K in operating cash flow during fiscal year 2022, representing cash generated from core business activities.

What are Retrieve Medical Holdings Inc's total assets?

Retrieve Medical Holdings Inc (rmhi) had $130K in total assets as of fiscal year 2022, including both current and long-term assets.

How many shares does Retrieve Medical Holdings Inc have outstanding?

Retrieve Medical Holdings Inc (rmhi) had 78M shares outstanding as of fiscal year 2022.

What is Retrieve Medical Holdings Inc's debt-to-equity ratio?

Retrieve Medical Holdings Inc (rmhi) had a debt-to-equity ratio of -1.27 as of fiscal year 2022, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Retrieve Medical Holdings Inc's return on assets (ROA)?

Retrieve Medical Holdings Inc (rmhi) had a return on assets of -126.6% for fiscal year 2022, measuring how efficiently the company uses its assets to generate profit.

What is Retrieve Medical Holdings Inc's cash runway?

Based on fiscal year 2022 data, Retrieve Medical Holdings Inc (rmhi) had $128K in cash against an annual operating cash burn of $69K. This gives an estimated cash runway of approximately 22 months at the current burn rate. Cash runway measures how long a company can continue operating before running out of cash, assuming no additional funding.

Why is Retrieve Medical Holdings Inc's debt-to-equity ratio negative or unusual?

Retrieve Medical Holdings Inc (rmhi) has negative shareholder equity of -$491K as of fiscal year 2022, which causes the debt-to-equity ratio to appear negative or not meaningful. This can occur when accumulated losses exceed invested capital, or after large share buyback programs. Other solvency metrics like the current ratio or interest coverage may be more informative.

What is Retrieve Medical Holdings Inc's Piotroski F-Score?

Retrieve Medical Holdings Inc (rmhi) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7–9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Retrieve Medical Holdings Inc's earnings high quality?

Retrieve Medical Holdings Inc (rmhi) has an earnings quality ratio of 0.42x, considered low quality (accrual-driven). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Retrieve Medical Holdings Inc cover its interest payments?

Retrieve Medical Holdings Inc (rmhi) has an interest coverage ratio of -5.1x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.